Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Harbor BioSciences ( (HRBR) ) has provided an update.
On December 30, 2025, Harbor Diversified, Inc. held its 2025 annual meeting of stockholders virtually via live webcast, with 41,098,970 of 58,429,836 eligible common shares present or represented by proxy. Stockholders elected three directors—Richard A. Bartlett, Nolan Bederman, and Kevin J. Degen—to serve until the 2026 annual meeting or until their successors are elected and qualified, reinforcing the company’s existing board structure while it continues to operate without a class of securities registered under Section 12 of the Exchange Act, thereby remaining outside many of the disclosure requirements typically applicable to public reporting companies.
More about Harbor BioSciences
Harbor Diversified, Inc., a Delaware corporation, is a company whose common stock is not registered under Section 12 of the Securities Exchange Act of 1934, which means it is not subject to certain disclosure and reporting obligations typically required of fully public reporting companies, such as filing proxy statements, information statements, tender offer disclosures, and beneficial ownership reports.
Average Trading Volume: 65,871
Technical Sentiment Signal: Buy
Current Market Cap: $96.41M
Learn more about HRBR stock on TipRanks’ Stock Analysis page.